MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
236.94%
Quick Ratio
236.94%
Cash Ratio
165.73%
Debt to Asset Ratio
38.21%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Short-term investments
    • Property and equipment, net
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Accounts payable
    • Others
Balance Sheets
2026-06-30
2025-12-31
2025-09-30
2025-06-30
Cash and cash equivalents
27,015
38,345
37,845
40,632
Short-term investments
4,471
5,997
16,936
31,136
Accounts receivable, net
2,936
13
17
0
Prepaid expenses and other current assets
4,201
6,574
7,799
5,988
Total current assets
38,623
50,929
62,597
77,756
Property and equipment, net
3,600
3,808
3,935
4,051
Right-of-use lease assets, net
561
647
737
825
Intangible assets, net
42
45
47
48
Other assets
646
646
45
45
Total assets
43,472
56,075
67,361
82,725
Accounts payable
2,016
1,964
1,994
2,294
Accrued liabilities
13,892
11,160
8,932
7,933
Contract liabilities
0
167
165
164
Current lease liabilities
393
322
336
350
Total current liabilities
16,301
13,613
11,427
10,741
Non-current lease liabilities
203
368
445
520
Other non-current liabilities
107
114
118
122
Total liabilities
16,611
14,095
11,990
11,383
Ordinary shares, 0.000174 par value 400,000,000 shares authorized 62,974,309 and 56,442,308 shares issued and outstanding at june 30, 2026 and december 31, 2025, respectively
11
10
10
10
Additional paid-in capital
465,509
444,176
442,544
441,413
Accumulated other comprehensive loss
-962
-1,191
-1,277
-1,375
Treasury shares
180
180
180
180
Accumulated deficit
-437,517
-400,835
-385,726
-368,526
Total shareholders' equity
26,861
41,980
55,371
71,342
Total liabilities and shareholders' equity
43,472
56,075
67,361
82,725
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$27,015K (-33.51%↓ Y/Y)Short-term investments$4,471K (-85.64%↓ Y/Y)Prepaid expenses andother current assets$4,201K (-29.84%↓ Y/Y)Accounts receivable, net$2,936K Total current assets$38,623K (-50.33%↓ Y/Y)Property and equipment,net$3,600K (-11.13%↓ Y/Y)Other assets$646K (1335.56%↑ Y/Y)Right-of-use lease assets,net$561K (-32.00%↓ Y/Y)Intangible assets, net$42K (-12.50%↓ Y/Y)Total assets$43,472K (-47.45%↓ Y/Y)Total liabilities andshareholders' equity$43,472K (-47.45%↓ Y/Y)Total shareholders'equity$26,861K (-62.35%↓ Y/Y)Total liabilities$16,611K (45.93%↑ Y/Y)Accumulated deficit-$437,517K (-18.72%↓ Y/Y)Accumulated othercomprehensive loss-$962K (30.04%↑ Y/Y)Treasury shares$180K (0.00%↑ Y/Y)Additional paid-in capital$465,509K (5.46%↑ Y/Y)Total currentliabilities$16,301K (51.76%↑ Y/Y)Non-current leaseliabilities$203K (-60.96%↓ Y/Y)Other non-currentliabilities$107K (-12.30%↓ Y/Y)Ordinary shares,0.000174 par value...$11K (10.00%↑ Y/Y)Accrued liabilities$13,892K (75.12%↑ Y/Y)Accounts payable$2,016K (-12.12%↓ Y/Y)Current leaseliabilities$393K (12.29%↑ Y/Y)

Connect Biopharma Holdings Ltd (CNTB)

Connect Biopharma Holdings Ltd (CNTB)